Risedronate released for Paget's disease.
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D017277:Drug Approval; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D000068296:Risedronic Acid; D014481:United States; D014486:United States Food and Drug Administration
D002121:Calcium Channel Blockers; D000068296:Risedronic Acid; D012968:Etidronic Acid